Dopamine News and Research

Latest Dopamine News and Research

Link between levels of urate in the blood and risk of Parkinson's disease

In a new, large-scale, prospective study exploring the link between levels of urate in the blood and risk of Parkinson's disease, researchers from the Harvard School of Public Health (HSPH) have found that high levels of urate are strongly associated with a reduced risk of the disease.

23 Jun 2007

Do common treatments for ADHD increase risk of drug abuse?

Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse.

19 Jun 2007

Researchers use 'genomic pathway' to predict Parkinson's

A new Mayo Clinic study provides strong evidence that the joint effects of common DNA variations in several genes that encode proteins within a well-defined biological pathway largely explain why some persons get Parkinson's disease while others don't, and even predict with great accuracy at what age people might develop their first symptoms.

17 Jun 2007

Isradipine may slow Parkinson's

Gloria E. Meredith, Ph.D., collaborated with D. James Surmeier, Ph.D. and other scientists at Northwestern University to study the drug, Isradipine, and its possible effects on Parkinson's disease.

17 Jun 2007

Injected neural stem cells reduce Parkinson's symptoms in primates

Primates with severe Parkinson's disease were able to walk, move, and eat better, and had diminished tremors after being injected with human neural stem cells, a research team from Yale, Harvard, the University of Colorado, and the Burnham Institute report in Proceedings of the National Academy of Sciences.

14 Jun 2007

Isradipine shown to slow down Parkinson's disease

Northwestern University researchers have discovered a drug that slows and may even halt the progression of Parkinson's disease.

14 Jun 2007

Cure for Parkinson's disease?

Scientists in the U.S. say they have discovered a drug that slows and might even stop the progression of Parkinson's disease.

11 Jun 2007

Scientists study glutamate system in the brains of living people

A newly started research collaboration between Karolinska Institutet and AstraZeneca has already generated results.

30 May 2007

In utero exposure to smoking associated with ADHD problems in genetically susceptible children

Women smokers who become pregnant have long been encouraged to reduce or eliminate their nicotine intake.

24 May 2007

Novel preclinical gene therapy approach for treating Niemann-Pick disease

Genzyme Corp. has announced the publication of a new study in The Proceedings of the National Academy of Sciences describing a novel preclinical gene therapy approach for treating Niemann-Pick disease.

24 May 2007

Parkin protein protects neurons from stress induced cell death

Parkinson’s disease, also known as shaking palsy, is one of the most frequent diseases of the nervous system.

22 May 2007

Implanting dopamine generators in brain cells improves Parkinson's in monkeys

Implanting dopamine generators (dopaminergics) in brain cells has produced improvement in the symptoms in Parkinson's, according to the results of tests carried out with monkeys by the Navarra University Hospital, led by Dr Mar'a Rosario Luquin Piudo, neurologist at the Hospital and at the other Navarra University-based medical centre, CIMA (the Research Centre for Applied Medicine).

17 May 2007

Exercise shows beneficial effects in patients with Parkinson's disease

A new study from researchers at the Keck School of Medicine of the University of Southern California (USC) shows that treadmill exercises may benefit patients with Parkinson's Disease and those with similar movement disorders.

16 May 2007

Patch to treat Parkinson's gets FDA green light

The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.

14 May 2007

Genetic component to autism

Using an innovative statistical approach, a research team from Washington University School of Medicine in St. Louis and the University of California, Los Angeles, has identified two regions of DNA linked to autism.

10 May 2007

FDA approves skin patch designed to treat symptoms of early Parkinson's disease

Rotigotine is a drug not previously approved in the United States. Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease.

10 May 2007

Electroconvulsive therapy helps patients with severe depression who don't respond to other treatments

Electroconvulsive therapy has been shown to be a highly effective, safe, and even life-saving treatment for persistent and severe depression, bipolar disorder, and schizophrenia.

8 May 2007

Phase III data on Safinamide in Parkinson's disease

Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.

4 May 2007

Submission of NDA for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug

Kyowa Hakko Kogyo Co. has announced that Kyowa Pharmaceutical, Inc., its wholly owned U.S subsidiary, submitted on April 25, 2007 a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for Istradefylline(KW-6002), its investigational drug for Parkinson's disease.

30 Apr 2007

Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure

In a first-of-its-kind study on humans, researchers measured how dopamine-related drugs affect the striatum, a part of the brain that is stimulated by rewards.

27 Apr 2007